GENE ONLINE|News &
Opinion
Blog

Antibody-Drug Conjugate
Editors' Picks Healthcare Industrybiotechbiopharma
GeneOnline’s Pick – Top 10 Global Industry News Stories in 2023 (Part 2)
2024-01-15
Trending JPMJP Morgan 2024
JPM 2024: Biotech Companies Mapping Out Their Future, and a New Round of M&A Spree Begins
2024-01-09
Trending Antibody-Drug ConjugateRocheSanofiBristol Myers SquibbSeagenBioNTech
Reviewing the Market Trends in the Antibody-Drug Conjugate Development: A Focus on Roche, Sanofi, BMS, Seagen, and BioNTech
2024-01-05
Partnerships ADC
SystImmune Partners with Bristol-Myers Squibb to Develop and Commercialize Bispecific ADC Globally
2023-12-13
Asia-Pacific Cancer
Daiichi Sankyo Advances Care Standards with Groundbreaking Cancer Treatment
2023-10-20
Special ASCOOncology
2023 ASCO Annual Meeting: Progress in Solid Tumor Treatment Research, and Promising Results in Emerging Therapies
2023-07-03
Partnerships Antibody-Drug ConjugateOncology
Pyramid Biosciences Bets $1B on Oncology Drug
2023-04-17
M&A PfizerSeagen
Pfizer Acquires Seagen for $43 Billion to Capture Leading Position in Oncology
2023-03-14
Asia-Pacific Antibody-Drug Conjugate
First Made-in-Singapore Antibody-Drug Conjugate Approved to Enter Clinical Trials
2023-01-09
Asia-Pacific Antibody-Drug Conjugate
Following Amgen, Hummingbird Jumps Onto Synaffix’s ADC Platform In $150 Million Licensing Deal
2023-01-06
Trials & Approvals Ovarian Cancer
ImmunoGen Wins FDA Accelerated Approval For Ovarian Cancer Drug
2022-11-16
Licensing Antibody-Drug Conjugate
Astellas and Sutro Team Up for Immunostimulatory Antibody-Drug Conjugates (iADCs)
2022-06-28
Trials & Approvals China
Everest and Gilead Announce Positive Phase 3 Results of Breast Cancer Drug
2022-06-06
Trials & Approvals Breast Cancer
FDA Grants AstraZeneca and Daiichi Sankyo’s Breast Cancer Drug Its Fifth Breakthrough Label
2022-04-28
China Peptide-drug Conjugates
Coherent Biopharma, WuXi STA Collab Takes a Crack at Peptide-Drug Conjugates
2021-12-06
1 2
LATEST
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
READ MORE
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top